Clinical Trials in Phoenix

Showing 1461-1480 of 16,646 trials

A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

NCT04644770

The purpose of this study is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) of JNJ-69086420 in Part 1 (Dose Escalation), to determine safety and preliminary signs of clinical activity at the RP2D(s) in Part 2 (Dose Expansion), to determine safety of JNJ-69086420 at the RP2D(s) as a combination therapy in Part 3 (combination therapy) and to determine safety of JNJ-69086420 at the RP2D(s) in participants with metastatic hormone-sensitive prostate cancer (mHSPC) in Part 4.

Prostatic NeoplasmsAdenocarcinoma

Janssen Research & Development, LLC144 participantsStarted Nov 2020

Phoenix, Arizona, United States • Duarte, California, United States • Jacksonville, Florida, United States +8 more locations

RECRUITINGPhase 211 miles

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

NCT04838301

A phase 2, double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of Allopregnanolone as a regenerative therapeutic for Alzheimer's disease.

Alzheimer DementiaLate Onset Alzheimer DiseaseNeurodegenerative Diseases

University of Arizona100 participantsStarted Aug 2023

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Costa Mesa, California, United States +7 more locations

A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

Find Trials by Condition in Phoenix

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)

Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome

A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

Varenicline for Smoking Reduction in Veterans Not Ready To Quit

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Terumo Aortic Global Endovascular Registry

Optimizing Reperfusion to Improve Outcomes and Neurologic Function

A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)